Program Overview
This online seminar on 30 July 2024 provides a comprehensive overview of the recent research advances on the management of Multiple Myeloma (MM) including optimization of induction and maintenance strategies in the first line setting and state of the art treatment of relapsed disease including bispecific antibodies and CAR-T cell results.
For the detailed program, click here.
Objectives and Learning Outcomes
Upon the completion of the course, attendees should be able to demonstrate competence in skills related to the theory and research applications in the field of Multiple Myeloma:
- Describe the most recent advances in the diagnosis, prognosis and treatment of newly diagnosed MM
- Be familiar with bispecific antibodies and CAR T cells in patients with relapsed MM
- Describe the state of the art management of AL amyloidosis
Target Audience
This seminar is designed for faculty members, principal investigators, post-doctoral research fellows, medical fellows, graduate students, and research assistants.
Recent Comments